Nixon Peabody
You are here:  Home  >  Central Coast Health Watch  >  Current Article

Amgen’s net income falls but earnings per share up

By   /   Tuesday, October 30th, 2018  /   Comments Off on Amgen’s net income falls but earnings per share up

    Print       Email
Net income for Thousand Oaks biotech giant Amgen fell 8 percent for the third quarter to $1.86 billion, but revenue and earnings per share both saw an uptick, spurred by strong new product sales and share buybacks. Product sales increased 1 percent overall compared to the same period the prior year, the company reported Oct.…


    This article is only available to Business Times subscribers
  • Subscribers: LOG IN or REGISTER for complete digital access.
  • Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists.
  • Check the STATUS of your Subscription Account.
    Print       Email

You might also like...

Wall Street loves AeroVironment’s latest acquisition

Read More →